Home
About
Overview
Sharing Data
ORCID
Help
History (60)
Localized hand-foot syndrome after intra-arterial hepatic chemotherapy with floxuridine: a clinical case.
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
FAK and paxillin, two potential targets in pancreatic cancer.
See All 60 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FAK and paxillin, two potential targets in pancreatic cancer.
FAK and paxillin, two potential targets in pancreatic cancer. Oncotarget. 2016 May 24; 7(21):31586-601.
View in:
PubMed
subject areas
Biomarkers, Tumor
Carcinoma, Pancreatic Ductal
Focal Adhesion Kinase 1
Humans
Models, Biological
Molecular Targeted Therapy
Pancreatic Neoplasms
Paxillin
Protein Kinase Inhibitors
Signal Transduction
authors with profiles
Ravi Salgia